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Abstract
Histone deacetylase 7 (HDAC7) plays a pivotal role in the maintenance of the endo-
thelium integrity. In this study, we demonstrated that the intron-containing Hdac7
mRNA existed in the cytosol and that ribosomes bound to a short open reading frame
(sORF) within the 50-terminal noncoding area of this Hdac7 mRNA in response to vas-
cular endothelial growth factor (VEGF) stimulation in the isolated stem cell antigen-1
positive (Sca1+) vascular progenitor cells (VPCs). A 7-amino acid (7A) peptide has
been demonstrated to be translated from the sORF in Sca1+-VPCs in vitro and
in vivo. The 7A peptide was shown to receive phosphate group from the activated
mitogen-activated protein kinase MEKK1 and transfer it to 14-3-3 gamma protein,
forming an MEKK1-7A-14-3-3γ signal pathway downstream VEGF. The exogenous
synthetic 7A peptide could increase Sca1+-VPCs cell migration, re-endothelialization
in the femoral artery injury, and angiogenesis in hind limb ischemia. A Hd7-7sFLAG
transgenic mice line was generated as the loss-of-function model, in which the 7A
peptide was replaced by a FLAG-tagged scrabbled peptide. Loss of the endogenous
7A impaired Sca1+-VPCs cell migration, re-endothelialization of the injured femoral
artery, and angiogenesis in ischemic tissues, which could be partially rescued by the
addition of the exogenous 7A/7Ap peptide. This study provides evidence that sORFs
can be alternatively translated and the derived peptides may play an important role in
physiological processes including vascular remodeling.
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1 | INTRODUCTION
Endothelial injury is a key event in the development of cardiovascular
diseases, whereas the regeneration of damaged endothelium is essential
for the protection against such diseases.1,2 Growth factors and the acti-
vation of local stem/progenitor cells capable to differentiate toward
endothelial cells play a pivotal role in this process.3,4 Vascular progenitor
cells (VPCs), which are mainly located in the adventitia, also contribute
to the repair of the injured endothelium via migration toward the endo-
thelium and differentiation into the endothelial cell (EC) lineage.5,6
In eukaryotic species, a single gene can produce multiple messenger
RNA (mRNA) molecules through the alternative splicing process, giving
rise to different protein variants with different, even opposite, func-
tions.7 Recent studies have shown that the translation of a peptide/
protein can be initiated from different start codon AUG or CUG (up to
15%) codons within a single mRNA molecule.8 Thus, a single mRNA
molecule may encode different peptides or proteins, which makes the
genetic information stored in the gene sequence even vaster.
Histone deacetylases (HDACs) are a family of enzymes that
remove acetyl groups from N-acetylated lysine residues on histones
and are involved in gene transcriptional regulation through modulating
chromatin structures. HDAC7, a member of the class II HDACs, is spe-
cifically expressed in the vascular endothelium and contributes to the
maintenance of vascular integrity during early embryogenesis.9-11 Due
to alternative splicing, there are 4 and 8 transcript variants in human
and mouse Hdac7 mRNA, respectively. In this study, we demonstrated
that a sORF within a mouse Hdac7 transcript variant could be trans-
lated, giving rise to a 7-amino-acid (7-aa) peptide (7A). This peptide
could act as a signal transducer through transferring a phosphate
group between a kinase and a substrate; this action modulated stem
cell antigen-1-positive VPC (Sca1+-VPC) activation and its effects on
vascular injury repair and angiogenesis in ischemic tissues.
2 | MATERIALS AND METHODS
2.1 | Materials
All cell culture media and serum were purchased from Thermo Fisher
Scientific (Waltham, Massachusetts), whereas cell culture supplements
and growth factors were purchased from Sigma (St. Louis, Missouri).
The peptides of 7A (MHSPGADC), MEKK1 (SRRS[pSer]RIKAPSRNTC),
and 14-3-3γ (KRA[pThr]VVESSEKAYSC) were synthesized and used to
raise anti-7A, anti-pMEKK1Ser393, and anti-p14-3-3γThr145 anti-
bodies in rabbit by GenScript (Piscataway, New Jersey). The antibodies
against CD31 (ab28364), Sca-1 (ab51317), 14-3-3γ (ab115176), and
MEKK1 (ab55653) were purchased from Abcam (Cambridge, UK). The
antibodies against phospho-Ser (P5872), phospho-Thr (P3555), FLAG
(F1804), and HA (H6908) were purchased from Sigma. The antibody
against GAPDH (sc-25 778), HDAC7(sc-74 563), and the siRNAs (con-
trol siRNA [sc-37007], MEKK1 siRNA [sc-35899], and 14-3-3γ siRNA
[sc-29 584]) were purchased from Santa Cruz Biotechnology (Dallas,
Texas). The antibodies against phosphohistidine (MABS1341, 1-pHis
clone SC50-3; MABs1352, 3-pHis clone SC56-2) were purchased from
Merck (Kenilworth, New Jersey). The antibody against pMKK4S257/
T261 (ABS160) was from Millipore (Berlin, Germany), and antibody
against MKK4 (9152 seconds) was from Cell Signaling Technology
(Leiden, The Netherlands). All secondary antibodies were purchased
from DAKO (Glostrup, Denmark). All other chemicals were purchased
from Sigma. All peptides (see list in Figure S6) and DNA fragments were
synthesized by GenScript.
2.2 | Cell culture
Sca1+-VPCs were isolated from the outgrowth of adventitial tissues of
mouse arterial vessels, as previously described.12,13 Briefly, the arterial
vessels were harvested from C57BL/6J mice (Charles River, Margate,
Kent, UK) or Hd7-7sFLAG transgenic mice and cut into 2-mm rings after
the removal of the intima and media; the pieces were placed in gelatin-
coated flasks and incubated at 37C in a humidified incubator sup-
plemented with 5% CO2 for 6 hours. Stem cell culture medium
([Dulbecco's modified Eagle medium (DMEM); ATCC, Rockville, Maryland]
supplemented with 10 ng/mL recombinant human leukemia inhibitory
factor [Chemicon, Temecula, California], 10% fetal bovine serum [FBS,
ATCC], 0.1 mmol/L 2-mercaptoethanol, 100 U/mL penicillin, and 100 U/
mL streptomycin) was added and refreshed every other day until the cells
reached 80% confluence. The cells were expanded and subjected to Sca-
1+ cell purification using anti-Sca-1 immunomagnetic microbeads Miltenyi
Biotec (Bergisch Gladbach, Germany). The purity of isolated Sca-1+ cells
was confirmed to around 85% using flow cytometry.12-14 The Sca-1+-
VPCs were maintained in stem cell culture medium and split every other
day. Cells passaged up to 30 times were used in this study, and
Sca1-selection was performed every five passages.
2.3 | Fluorescence in situ hybridization
Sca1+-VPCs were seeded at a density of 104 cells/well on gelatin-coated
ϕ13mm coverslip in 24-well plates in differentiation medium and incu-
bated for 24 hours. The cells were cultured in alpha-minimum essential
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medium (alpha-MEM) supplemented without serum for 4 hours, then
treated with 5 ng/mL vascular endothelial growth factor (VEGF; VEGF-
164, R&D systems, Minneapolis) for 30 minutes, followed by fixation with
4% paraformaldehyde/phosphate-buffered saline (PBS) solution at room
temperature for 15 minutes. Fifteen minutes prior to fixation, 10 μg/mL of
puromycin was added. Same volume of 1% bovine serum albumin (BSA)
and dimethyl sulfoxide (DMSO) were included as control for VEGF and
puromycin, respectively. The fixed cells were washed three times with PBS
at 5 minutes each, permeabilized with 0.2% Triton X-100/PBS at room
temperature for 30 minutes, followed by washing with PBS for three times
at 5 minutes each. The cells were then prehybridized with 400 μL/well
prehybridization buffer (6× saline sodium citrate [SSC]), 5% BSA, 100 μg/
mL single-stranded salmon sperm DNA, 10 mM EDTA) at 42C water bath
for 1 hour. After the removal of the prehybridization buffer, 400 μL/well
of hybridization buffer (prehybridization buffer containing 0.4 μmol/L of
the Alexa Fluor-488/594-labeled cDNA probes) was added and incubated
at 42C water bath for 1 hour, followed by washing with 1× SSC for
5 times at 5 minutes each. The nucleus was counterstained with DAPI for
5 minutes, followed by two washings with 1× SSC. The probe sequences
were:50 > AlexaFluor594-ccgcgccggggctgtgcatccagggg<30 and 50>Alexa
Fluor488-gaatgtcttagcaggctgtggggactcact<30(Sigma). The coverslips were
picked up and placed upside down on slides with fluorescence mounting
medium (DAKO) and subjected to confocal microscope observation and
image taken. Images were taken using an SP5 confocal microscope (Leica,
Germany) and processed using Adobe Photoshop software. Magnification
is indicated in figure legends as scale bars.
2.4 | Immunofluorescence staining
Mouse tissues were harvested and immediately frozen with liquid
nitrogen. The frozen tissues were then embedded in optical coher-
ence tomography at −20C, followed by cryosection with a thickness
of 5–10 μm. The cells cultured on slides or the cryosections were
fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton
X-100 in PBS for 15 minutes, and blocked with 10% FBS/PBS for
1 hour. The primary antibodies were diluted in 10% FBS/PBS by the
dilution factor recommended by the suppliers, applied to the cell sam-
ples and incubated at 37C for 1.5 hours or at 4C overnight. The sec-
ondary antibodies were diluted at 1:1000 in 10% FBS/PBS, then
applied and incubated at 37C for 45 minutes. The cell nucleus was
counterstained with DAPI at room temperature for 5 minutes, and
coverslips were mounted on slides with fluorescent mounting media.
For 7A blocking experiments, the anti-7A antibody was preincubated
with 7A (1 μg Ab:1 μg peptide) overnight and then used as the same
dilution factor as the nonblocking antibody.
2.5 | Enzyme-linked immunosorbent assay
For enzyme-linked immunosorbent assay (ELISA) performed on cells,
the undifferentiated or 3-day differentiated Sca1+-VPCs were seeded
in 96-well plates and treated as described in the figure legends. The
cells were fixed with 4% paraformaldehyde at room temperature for
10 minutes, permeabilized with 0.1% Triton X-100 in PBS for
15 minutes, treated with 3% H2O2 for 20 minutes to quench endoge-
nous horseradish peroxidase (HRP), and blocked with 10% FBS/PBS for
1 hour, followed by incubation with primary antibodies at 37C
for 1 hour and HRP-conjugated secondary antibodies at 37C for
45 minutes. The associated HRP was revealed by incubation with phos-
phate citrate buffer (50 mmol/L phosphate-citrate, pH 5.0, 0.03%
sodium perborate) containing 0.17 mg/mL of o-dianisidine
dihydrochloride, and absorbance was measured at 405 nm by a Genios
Pro-Tecan microtiter plate reader (MTX Lab Systems, Inc., Virginia). For
ELISA on peptides, 100 μL of peptides in PBS (0.1 mg/mL, 7Sp, 7Avp,
7Ap, b-7Ap, and 7Ap-b) were added to 96-well microtiter plates in trip-
licate and incubated at 37C overnight. PBS and VEGF (5 ng/mL)-
treated Sca1+-VPCs cell lysate (100 μL at 0.1 mg/mL) were included as
control. The plates were then fixed with 4% paraformaldehyde at room
temperature for 10 minutes, treated with 3% H2O2 for 20 minutes to
quench endogenous HRP, and blocked with 10% FBS/PBS for 1 hour,
followed by similar procedure as described above. For ELISA on beads,
the immunoprecipitation beads or biotin-peptide pull-down assay beads
were incubated with primary and HRP-conjugated secondary antibodies
as described above, with A405 nm measured on a Bio-Rad Smartpec
Plus Spectrophotometer (Hercules, California).
2.6 | Immunoprecipitation and biotin-peptide
pull-down assay
The cells were lysed in lysis buffer (10 mmol/L Tris-Cl pH 7.5,
120 mmol/L NaCl, 1 mmol/L EDTA pH 8.0, 1% Triton X-100 plus pro-
tease inhibitors [Roche]) by rotation at 4C for 1 hour. The protein con-
centration was measured with Biorad Protein Assay (BIO-RAD,
5000006) by the protocol provided. For the immunoprecipitation assay,
1 mg cell lysate was incubated with 2 μg primary antibody or normal
IgG and three volumes of Triton X-100-free lysis buffer on a rotator at
4C for 2 hours. Then, 10 μL Protein G-agarose beads (Sigma) was
added, and the liquid was incubated for another 2 hours followed by
PBS washing and ELISA assays. For the biotin-peptide pull-down assay,
5 μg biotin-labeled peptide was incubated with 50 μg cell lysates and
three volumes of Triton X-100-free lysis buffer at 37C for 1 hour.
Then, 10 μL streptavidin-agarose beads (Sigma) was added, and the liq-
uid was incubated for an additional hour followed by washing six times
with lysis buffer containing 0.5% Triton X-100. The beads were incu-
bated with 1× sodium dodecyl sulfate (SDS) loading buffer (10 mmol/L
Tris-Cl pH 7.5, 120 mmol/L NaCl, 2% SDS, 5% glycerol, 0.025% brom-
ophenol blue, 1% 2-mercaptoethanol). The eluate was subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
followed by Western blot or proteomics analysis (Computational Biol-
ogy Research Group, Oxford University). The beads were washed six
times with lysis buffer containing 1% SDS followed by the ELISA assay.
2.7 | RNA extraction
Total RNA extraction from Sca-1+ progenitor cells was performed by
applying RNeasy Mini kit (QIAGEN Inc., 74 106). According to manu-
facturer's instruction, cells were washed three times by PBS, disrupted
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by proportional amount of RLT lysis buffer, and then scraped off from
the 6-well plate or T25 flasks. The lysate was transferred into a mini
QIAshredder spin column and centrifuged at full speed for 2 minutes.
Same volume of 70% ethanol was added to the lysate and the mixture
was transferred to RNeasy mini column for a 35-second centrifuge at
full speed. The flow was discarded and 700 μL of RW1 was added to
RNeasy mini column. After 30-second centrifuge, the flow was dis-
carded and 500 μL of RPE was added to the column twice for washing
away the ethanol. The flow was then discarded and the column was
centrifuged within a new collection tube for 2 minutes at full speed to
ensure no solution outside the column. At last, the RNeasy mini column
was transferred into a new 1.5 mL RNA-free tube, and 35 μL
diethypyrocarbonate (DEPC) water (Invitrogen) was added to the mem-
brane of the column, followed by 1-minute centrifuge at full speed. The
RNA concentration was measured by a nanodrop spectrophotometer
ND-1000 (Thermo Fisher Scientific, UK) at the absorbance at 280 nm.
2.8 | Reverse transcription
Reverse transcription (RT) was achieved by Quanti Tect Reverse Tran-
scription Kit (Qiagen, 205 311), according to the manufacturer's
instructions. Briefly, 1 μg of RNA template, 2 μL of gDNA wipeout
buffer and enough volume of RNase-free water were mixed in the
tube with a total volume 14 μL. The tube was placed in a RT-
polymerase chain reaction (PCR) machine (TECHNE TC-412, Bibby
Scientific, UK) at 42C for 2 minutes, after which 1 μL of RT enzyme,
1 μL of primer mix and 4 μL of RT buffer, making up to 6 μL of reac-
tion volume, was added to the tube mentioned above. Then the mix-
ture was incubated at 42C for 15 minutes and subsequently 95C for
3 minutes. The cDNA obtained was diluted into 100 μL by using
DEPC-treated water, acquiring a final concentration of 10 ng/μL.
2.9 | Quantitative real-time PCR
Quantitative real-time PCR was performed by applying SYBR green
system (Qiagen, 204 057). The target gene was amplified in a duplex
in 20 μL PCR mixtures (10 μL Sybr Green, 2 μL cDNA template, 1.6 μL
optimized primers, and 6.4 μL DEPC water) which was loaded into a
96-well plate (Eppendorf White, Eppendorf, UK). The plate was cen-
trifuged at 1000 rpm for 5 minutes before running the program in
qPCR machine. Ct values were established using EPPENDORF
Mastercycler ep realplex. GAPDH served as an endogenous control.
2.10 | Western blot analysis
Cells with or without treatment were lysed using RIPA buffer (Life Tech,
89 901) with phosphatase inhibitor tablets (Roche, 04906845001) and
protease inhibitors (Roche, 11 873 580 001). The lysate was sonicated
using a Branson Sonifier 150 at level 1 for 6 seconds twice prior to
50-minute incubation on ice. The lysate was then centrifuged at
15 000g for 12 minutes at 4C. The supernatant was collected and
transferred to a new 1.5 mL tube. The concentration of proteins was
measured by performing Biorad Protein Assay (BIO-RAD, 5000006). A
20 μg of lysate mixed with SDS loading buffer was loaded into a
NuPage 4%-12% Bis Tris-gel immersed in NuPage MOPS SDS running
buffer, followed by standard Western blot procedures.
2.11 | In-gel phosphorylation
The recombinant 14-3-3 γ protein (H00007532-P01) was purchased
from Novus Biologicals (Littleton, Colorado). One hundred nanograms
of 14-3-3γ protein were diluted in 250 μL of 1× SDS loading buffer,
and 25 μL per lane of the diluted 14-3-3γ protein was applied to SDS-
PAGE. One lane together with the protein marker was cut and sub-
jected to silver staining (Thermo Fisher Scientific) by the protocol pro-
vided. The 14-3-3γ protein bands in the remaining gel were cut and
incubated in Novex Zymogram Renaturing buffer (Thermo Fisher Sci-
entific) at room temperature for 1 hour. After washing three times
with tris-buffer saline and tween 20 (TBST) buffer (25 mmol/L Tris-Cl
pH 7.5, 120 mmol/L NaCl, 1 mM EDTA pH 8.0, 0.1% Tween 20), the
gel bands were incubated in an equal volume of TBST containing
2 ng/mL peptides at 37C for 30 minutes. The bands were
reorganized and transferred to Hybond polyvinylidene difluoride
membrane (GE Health) followed by a standard Western blot
procedure.
2.12 | siRNA knockdown assay
The Sca1+-VPCs were subcultured 1:3 in differentiation medium in
fibronectin-coated T25 flasks. Twenty-four hours later, the cells were
washed twice with and incubated in serum-free DMEM containing
0.05 mmol/L 2-mercaptoethanol for 1 hour. Ten microliters of
10 μmol/L siRNA/flask was introduced into the cells with Lipofectamine
RNAiMax transfection reagent (Thermo Fisher Scientific) according to
the protocol provided. The transfected cells were further cultured in dif-
ferentiation medium for 72 hours followed by 5 ng/mL of VEGF treat-
ment in serum-free medium for 30 minutes and ELISA assays and
Western blot analysis.
2.13 | Transwell migration assay
Of note, 3 × 104 Sca1+-VPCs in 200 μL serum-free DMEM were
seeded in the insert of 24-well transwell with 8 μm pore and placed in
the 24-well transwell plate with the holder containing 600 μL/well of
DMEM plus 1 ng/mL peptide and/or 5 ng/mL VEGF. The whole set
was placed in cell culture incubator and incubated for 6 hours, followed
by staining with crystal violet. After removal of the cells inside the
insert, the migrated cells on the outside membrane of the insert were
observed under microscope. Images were taken and cell number was
calculated with ImageJ. The experiments were performed in triplicate.
2.14 | Image quantification
For the study of CD31+ and Sca1+ cells in skeletal muscle of ischemic
legs, immunofluorescence images were obtained in a blinded manner
from three different fields of each animal. With the ImageJ software,
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each image was converted into a binary image, and the integrated
density (DInt) and area were calculated. Then, the values were
corrected by the number of nuclei.
2.15 | Hd7-7sFLAG transgenic mice generation,
femoral artery injury, and hind limb ischemia
All animal experiments were performed according to protocols
approved by the Institutional Committee for Use and Care of Labora-
tory Animals, and all the procedures conformed to the guidelines from
Directive 2010/63/EU of the European Parliament. A single dose of
ketamine (75 mg/kg) and medetomidine HCl (1 mg/kg) were injected
into peritoneal cavity. After surgery, the mice were kept in a warm
incubator until they got awake.
The Hd7-7sFLAG transgenic mice were generated by Cyagen Biosci-
ences Inc. (Santa Clara, California), in which the 7A sequence
(MHSPGAD, ATGCACAGCCCCGGCGCGGACTGA) was replaced by the
scrabbled 7S sequence (MPHASGD) tagged with a FLAG sequence
(MPHASGDYKDDDDKAD, ATGCCCCACGCGTCGGGCGACTACAAA
GACGATGACGACAAGGCGGACTGA). This handling only affects the
first 5-aa within the 7A ORF without any change to the promoter or the
exon splicing sites. Therefore, the transcription and splicing of HDAC7
mRNA should not be affected. This transgenic mouse line can serve as a
knockout model for 7A.
The femoral artery injury model was introduced into WT and KO
mice as previously described.15 The uninjured sham control was
included. Six mice were used for each group. The injured vessels were
harvested at days 3, 7, and 21 postsurgery and cryo-sectioned,
followed by immunofluorescence staining (days 3 and 7) or
Hemotoxylin and Eosin (H&E) staining (day 21). The hind limb ische-
mia model was introduced into WT and KO mice as previously
described.16 Briefly, the femoral artery in the left leg was banded and
cut. Six mice were used for each group. The foot blood perfusion was
scanned on both legs using the Doppler Scanner at 30 minutes, days
7 and 14 post-surgery. The images were analyzed with the software
moorLDI V6.0. The mice were sacrificed humanely at day 14, and the
leg skeletal muscle tissues were harvested and cryosectioned,
followed by immunofluorescence staining. For the rescue experiments
in both types of mouse models, 200 μL of 25% Pluronic-127 gel con-
taining 10 ng/mL of 7A peptide was applied surrounding the injured
vessels.
2.16 | Statistical analysis
The data expressed as the mean ± standard error of the mean were
analyzed using GraphPad Prism 7 with a t test for pairwise comparisons
or analysis of variance, followed by multiple comparison tests for com-
parisons involving more than two groups, and significance is depicted
by asterisks, *P < .05; **P < .01, ***P < .001. A value of P < .05 was con-
sidered to be significant.
2.17 | Statement of animal studies
All animal experiments were performed according to the protocols
approved by the Institutional Committee for Use and Care of Labora-
tory Animals under the UK Home Office Project License PPL70/7266.
3 | RESULTS
3.1 | The 7-aa peptide could be translated in vitro
and in vivo
In the 50 untranslated region (UTR) of mouse Hdac7 transcript variant
2 (NM_001204276.1), there is a sORF encoding a 7-aa peptide (7A,
MHSPGAD) with three cascade in-frame stop codons. Our previous
studies demonstrated that this Hdac7mRNA underwent further splicing
to remove these stop codons, joining the sORF with the main ORF.17
These findings suggest that the ATG start codon in the sORF can initi-
ate translation. As three in-frame sequential stop codons exist in the
sORF, we speculated that this sORF might be translated alone. To test
this, we firstly performed a FISH (fluorescence in situ hybridization)
experiment. The Sca1+-VPCs were isolated from the adventitia of arte-
rial vessels via Sca1+ cell sorting13,18 with around 85% purity and
treated with 5 ng/mL VEGF in the absence or presence of 10 μg/mL
puromycin, followed by hybridization with Alexa Fluor 488- and
594-labelled oligo DNA probes, which were complementary to the
intron and the sORF sequences, respectively (Figure S1A). The two
complementary sequences for these two probes are next to each other.
If they bind to the same molecule, an overlapped fluorescence signal will
appear. Indeed, we observed a few cells contained some spots with an
overlapped fluorescence signal in the cytoplasm (Figure 1A and
Figure S1B with arrow indication). VEGF could increase such spots
number and positive cell number. These results suggest that the intron
containing mRNA exists in the cytoplasm. Most importantly, the pres-
ence of puromycin significantly increased the number of the overlapped
spots in the cytosol within single cell and the number of cells containing
such spots (see images for puromycin vs DMSO in Figure 1A and
Figure S1B). Puromycin can remove ribosome from the mRNA
molecule,19 which makes the mRNA accessible to the probes. These
results not only demonstrate the existence of the intron-containing
mRNA in the cytosol but also indicate the binding of ribosome to the
sORF. We also noticed that the presence of puromycin increased red
signal in the nucleus, reflecting that the transcription and splicing of the
intron in the nucleus was also increased. To assess whether the binding
of ribosomes to sORF led to the 7A peptide translation, we raised a spe-
cific antibody against this 7A peptide and performed double immunoflu-
orescence staining together with anti-HDAC7 antibody. If the sORF
joins the main ORF, the fluorescence for 7A and HDAC7 will overlap.
The nonoverlapped fluorescence will suggest the separate translation of
the 7A peptide and HDAC7 protein. As expected, some overlapped sig-
nal was observed (arrows in Figure 1B) but the majority was
non-overlapped and both types of signals were enhanced by VEGF
treatment (Figure 1B). The pre-incubation of anti-7A antibody with 7A
peptide totally blocked 7A staining (Figure 1B, 7A blocking). These
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F IGURE 1 7A could be translated in vitro and in vivo. A, The 57-bp intron containing Hdac7 mRNA existed in the cytosol as revealed by
fluorescence in situ hybridization with Alexa Fluor-594 and Alexa Fluor-488-labeled oligo DNA probed complementary to the short open reading
frame and intron sequences respectively. Sca1+-VPCs were treated with 5 ng/mL vascular endothelial growth factor (VEGF) for 30 minutes in the
absence or presence of 10 μg/mL puromycin (last 15 minutes), followed by hybridization. B, VEGF enhanced 7A expression in Sca1+-VPCs.
Sca1+-VPCs were treated with 5 ng/mL VEGF for 30 minutes, followed by double immunofluorescence staining with anti-7A (red) and anti-
HDAC7 (green) antibodies. 7A blocking indicates that the anti-7A antibody was preincubated with synthetic 7A peptide (1:1) overnight. Data are
presented as mean ± SD, n = 12 cell cultures per group from three individual preparations. For statistical analysis, the Student's t test was used.
*P < .05. C, Vascular injury induced 7A expression in Sca1+ cells. Femoral artery injury was introduced into C57BL/6J mice (n = 6). The injured
arteries were harvested at day 7 postsurgery, followed by immunofluorescence staining with anti-7A (green) and HDAC7 (red) or Sca1 (red)
antibodies. White arrowhead showed HDAC7, white arrow showed 7A, green arrow showed 7A+/Sca1− cell, red arrow showed 7A+/Sca1+ cell.
The data presented are representative images of three independent experiments or from six mice per group for in vivo experiments. VPC,
vascular progenitor cell
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results suggest that the sORF can indeed be translated alone to produce
the 7A peptide and that VEGF stimulation can enhance this process.
Considering the in vitro-cultured Sca1+-VPCs were already acti-
vated cells, we speculated whether the endogenous 7A peptide was
expressed constitutively in Sca-1+ cells or only under stimulation
in vivo. To test this, we performed immunofluorescence staining on sec-
tions from injured and uninjured mice femoral arteries. As shown in
Figure 1C, there was positive staining for both HDAC7 and Sca-1 but
not for 7A peptide in uninjured vessels. Neither HDAC7 nor 7A was
detected in the media layer of the uninjured femoral artery. However,
positive staining for 7A (white arrows in Figure 1C) peptide and HDAC7
(white arrowhead in Figure 1C) was detected in the activated and
migrated Sca-1+ cells (red arrow in Figure 1C) in the injured vessels.
There were some 7A+/Sca-1− cells (green arrow in Figure 1C) in the
outer layer, the identity of these cells needs further investigation.
Although there was nonspecific signal from the blood clot in the lumen,
the 7A staining on the vessel wall was totally blocked by the pre-
incubation of the antibody with the synthetic 7A peptide. The
costaining of 7A/HDAC7 and 7A/Sca-1 suggests that 7A and HDAC7
are co-translated in the activated Sca-1+ cells. In some cells, the staining
for 7A and HDAC7 overlapped, which may suggest there is a splicing
event and the 7A peptide joins the main protein.17 Further experiments
with mouse heart tissues revealed that both 7A and HDAC7 were
expressed in endothelium, some of the signal were overlapped
(Figure S2). The difference on 7A and HDAC7 expression between cor-
onary artery and femoral artery may reflect the EC heterogeneity along
the arterial.20 Different Hdac7 mRNA transcript variants or protein
isoforms may be expressed in different part of the arterial tree.
Recently, we published some data on the role of 7A in EC differ-
entiation and its contribution to tissue engineered vessel graft21 and
protection in cardiac fibrosis via hydrogel implication.22 In this study,
we focused on the demonstration of the translation of the 7A peptide
and its function in signal transduction and vascular remodeling.
3.2 | 7A deficiency attenuated vascular injury repair
and angiogenesis in ischemic tissues
To better understand the function of 7A in vivo, we created a trans-
genic mouse line, Hd7-7sFLAG, in which the first 5 amino acid of the
sORF (MHSPG of MHSPGAD) was replaced by a 7S sequence that was
tagged with a FLAG sequence (MPHASGDYKDDDDKA) through
homologous recombination (Figure S3A). The last three nucleotides
within the exon 1 of Hdac7 mRNA (NM_001204276.1) remained
unchanged. Thus theoretically, the transcription and normal splicing of
this transcript variant should not be affected. However, the replacement
may affect its further splicing.17 The expression of FLAG can serve as
an indicator for the endogenous expression of the 7A peptide. Indeed,
FLAG-positive Sca1+ cells were detected in the adventitia of the aorta
in transgenic mice (Figure S3B). This mice line can therefore serve as
the knockout mice for the 7-aa peptide. As the Hdac7 mRNA transcript
variant will not be able to undergo further splicing, the mice line can also
serve as a model to investigate the role of the 22 amino acid in the
N-terminal of HDAC7 protein. In this study, we just focused on the
7-aa peptide. We assessed the transcription of Hdac7 mRNA from P1
and P2 promoters in lung and spleen tissues by quantitative RT-PCR.
There was no difference in lung between the wild-type and the
7A-deficient mice [Hd7-7sFLAG+/+ (KO)], but KO mice had slightly
higher Hdac7 mRNA (from both P1 and P2 promoters) in spleen tissues
(Figure S3C). Western blot analysis revealed that there was no signifi-
cant difference between wide-type and KO mice, although spleen tis-
sues showed abundant HDAC7 protein (Figure S3D). As we have
shown that 7A and HDAC7 were expressed differentially in different
tissues or organs, it would be worthy to enrich ECs and VPCs from the
different organs or tissues to assess Hdac7 transcription from different
promoters and their translation regulation in future studies.
Our recently published data have shown that 7A especially 7Ap
could increase angiogenesis in ischemic tissues and that inclusion of
7Ap in tissue engineered vessel graft could increase Sca1+-VPCs
recruitment in the grafts.21 To further investigate whether the transla-
tion of 7A in Sca1+-VPCs contributes to re-endothelialization in vascu-
lar injury repair and angiogenesis, we generated femoral artery injury
and hind limb ischemia models using WT and KO mice.
In the femoral artery injury model, many Sca1+-VPCs could be
observed on days 3 and 7 as well as obvious re-endothelialization on day
7 in WT mice (Figure 2A, left). Considerably fewer Sca1+-VPCs were
observed in KO mice, and there was no obvious re-endothelialization
(Figure 2A, middle). Local administration of the 7A peptide via Pluronic-
F127 gel significantly improved re-endothelialization (Figure 2A, right).
The overlapped signal was observed in the endothelium of KO + 7A
group at day 7 (Figure 2A right bottom), suggesting that 7A increased
Sca1+-VPCs differentiation into ECs and contribution to endothelium
injury repair. These results suggest that the translation of 7A can contrib-
ute to Sca1+-VPC activation and the re-endothelialization of injured blood
vessels. Vascular injury is usually linked to neointima formation. However,
in this study, we did not observe obvious neointima formation in either
WT or KO mice within 3 weeks (Figure S4). Local administration of the
7A peptide to KO mice slightly decreased the media thickness (Figure S4).
In the hind limb ischemia model, the KO mice showed a severe
reduction in or loss of foot blood supply as revealed by Doppler scan-
ner measurement (Figure 2B and C). Local delivery of the 7A peptide
partly rescued this phenotype (KO + 7A in Figure 2B and C). Due to
the poor blood supply, all KO mice developed moderate to severe foot
necrosis, and two mice even lost the foot (Figure S5). All WT mice had
mild necrosis on day 7 but recovered to the minimal level on day
14 (Figure S5). Local administration of the 7A peptide to KO mice sig-
nificantly improved the necrosis to moderate or mild level (Figure S5).
Immunofluorescence staining of the skeletal muscle tissues isolated
from the injured leg with anti-Sca1 and anti-CD31 antibodies showed
that there were considerably fewer Sca1+ cells in KO mice than in WT
mice, and local administration of the 7A peptide significantly
increased the number of Sca1+ cells (Figure 2C). There were slightly
less CD31+ cells in KO mice (Figure 2C). These results indicate that
the endogenous 7A peptide may participate in Sca1+-VPC activation
and affect its contribution to angiogenesis in ischemic tissue; further-
more, the exogenous 7A peptide may have therapeutic potential in
the treatment of angiogenesis-related diseases.
562 YANG ET AL.
3.3 | VEGF induced 7-aa peptide phosphorylation via
MEKK1
To investigate how 7A promote angiogenesis, we focused on 7A amino
acid sequence, which contains an adjacent histidine and serine residue,
the two of the four normally phosphorylated amino acids in eukaryotic
proteins. Therefore, we wondered whether there was a phosphoryla-
tion event within the 7A peptide. To test this, we performed a special
biotin-labeled peptide pull-down assay (Figure S6A). The biotin-labeled
peptides were incubated with VPC lysates and pulled down with
streptavidin magnetic beads. ELISA with an anti-phospho-Ser antibody
detected a positive signal in the bio-7A/streptavidin beads, which was
enhanced by VEGF treatment (Figure 3A); these findings demonstrate
that 7A can be phosphorylated. This phosphorylation might be
sequence-specific, as the serine residue in the scrabbled 7A peptide (7S,
MPHASGD) was not phosphorylated (Figure 3A). As expected, the
F IGURE 2 7A deficiency reduced re-endothelialization in injured vessels and angiogenesis in ischemic tissues. A, 7A deficiency reduced re-
endothelialization in injured vessels, which was partly rescued by local administration of the 7A peptide. Femoral artery injury was introduced in
WT or KO mice. Some KO mice received 200 μL of Pluronic F-127 gel containing 10 ng/mL 7A peptide (KO + 7A). The injured vessels were
harvested on days 3 and 7 postsurgery and subjected to cryo-sectioning and double immunofluorescence staining with anti-Sca1 (green) and anti-
CD31 (red) antibodies. The nuclei were counterstained with DAPI. B-D, 7A deficiency attenuated the recovery of foot blood perfusion in the hind
limb ischemia model, which was partly rescued by local administration of the 7A peptide. Hind limb ischemia was induced in WT or KO mice via
femoral artery ligation, and some KO mice received 200 μL of Pluronic F-127 gel containing 10 ng/mL 7A peptide (KO + 7A). Foot blood
perfusion was measured by a Doppler Scanner on days 7 and 14 postsurgery (B, C). The mice were sacrificed on day 14, and Sca1+ (red) and
CD31+ (green) cells in skeletal muscle tissue sections from the uninjured and injured legs were analyzed. The data presented are representative
images or the mean values of six mice for each group. For statistical analysis, two-way analysis of variance test followed by Tukey's multiple
comparisons test was used. *P < .05
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F IGURE 3 MEKK1 phosphorylated 7A upon vascular endothelial growth factor (VEGF) treatment. A, VEGF enhanced 7A phosphorylation. Biotin-
labeled peptides were incubated with cell lysates of VEGF-treated/untreated Sca1+-VPCs, followed by streptavidin beads pull-down and enzyme-linked
immunosorbent assays (ELISAs) with anti-phospho-Ser antibody. B, The 7Aa peptide interacted physically with MEKK1. The bio-peptide/protein
complex was trapped by streptavidin beads and subjected to Western blot analysis. C, VEGF transiently activated MEKK1 phosphorylation. Sca1+-
VPCs (1 × 106) were treated with 5 ng/mL VEGF in serum-free medium for the indicated times and then subjected toWestern blot analyses. D-G, The
7Aa peptide retained MEKK1 phosphorylation. Sca1+-VPCs were treated with 5 ng/mL VEGF in the presence of 1 ng/mL peptides for the indicated
times and subjected to ELISA (D) or for 30 minutes and subjected to Western blot analyses (E) or immunofluorescence staining (F, Scale bar: 25 μm, G
quantification). Data are presented as mean ± SD, n = 12 cell cultures per experimental group from three individual preparations. H,Mekk1 knockdown
attenuated VEGF-mediated 7A phosphorylation. Sca1+-VPCs(5 × 105) were transfected withMekk1 siRNA (Mekk1si) and cultured for 3 days, followed
by 5 ng/mL VEGF treatment for 30 minutes. Control siRNA (ctlsi) and 1% bovine serum albumin were included as controls. The cell lysates were
subjected to bio-peptide/streptavidin beads pull-down arrays followed by ELISAs with an anti-phospho-Ser antibody. The data presented are
representative images or the mean values of three independent experiments. For statistical analysis, the two-way analysis of variance (ANOVA)
followed by Tukey's multiple comparisons test was used in (A, B, E, G); the one-way ANOVA followed by Holm-Sidak's multiple comparisons test was
used in (C, D); and the Student's t test was used in (H). *P < .05; **P < .01. 7A, 7-aa peptide; 7Aa, 7-aa peptide with a serine substituted with an alanine;
7S, scrabbled 7-aa peptide; b-7S/7A/7Aa, biotin-labeled 7-aa peptides. VPC, vascular progenitor cell
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substitution of serine with alanine (7Aa, MHAPGAD) totally abolished
7A phosphorylation (Figure 3A). All 7-aa peptides used in this study
were listed in Figure S6B.
To identify the potential upstream kinases for 7A phosphorylation,
we performed a pilot proteomics analysis of peptide-associated pro-
teins using the special peptide/protein pulldown assay as described
above to search for phosphorylation changes in response to VEGF
treatment. In these assays, the biotin-labeled 7Aa was included. As
Ala substitution for Ser blocks the phosphate transfer from kinase to
7A, it may have more chance to detect phosphor-peptides in bio-7Aa
associated kinases. We identified approximately 40 kinases associated
with some of the biotin-labeled 7-aa peptides (see Figure S7A). The
number of the total and the phosphorylated peptides were listed for
the mitogen-activated protein kinases (see Figure S7B). Indeed, a
phosphorylated peptide (RSSRIK) from MEKK1 was detected in the
bio-7Aa samples. Therefore, MEKK1 was considered as a potential
upstream kinase. To verify this, we raised a specific anti-phospho-
MEKK1S393 antibody with the peptide SRRS (pSER)RIKAPSRNTC.
With this antibody, we confirmed the association of bio-7Aa and
phosphorylated MEKK1 upon VEGF treatment (Figure 3B). Interest-
ingly, b-7S was also associated with MEKK1 (Figure 3B). The
7S sequence actually existed in some other proteins. The binding of
7S to MEKK1 might reflect the association of MEKK1 with
7S-containing proteins, which may provide some clues to identify
MEKK1 target proteins. Further experiments revealed that VEGF
induced a transient increase in MEKK1S393 phosphorylation, which
peaked at 10 minutes posttreatment (Figure 3C). Interestingly, the
presence of 7A slightly decreased MEKK1 phosphorylation, whereas
the addition of 7Aa maintained MEKK1 phosphorylation, as revealed
by ELISA (Figure 3D), Western blot (Figure 3E), and immunofluores-
cence staining (Figure 3F&3G). To further confirm the involvement of
MEKK1 in 7A phosphorylation, siRNA-mediated Mekk1 knockdown
was performed. As shown in Figure 3H, Mekk1 knockdown signifi-
cantly attenuated VEGF-induced 7A phosphorylation. These results
suggest that MEKK1 may function as an upstream kinase for 7A
phosphorylation.
3.4 | The phosphorylated 7A facilitated 14-3-3γ
protein phosphorylation
The 14-3-3 proteins are a family of conserved regulatory molecules
ubiquitously expressed in all eukaryotic cells. Our previous study
reported that HDAC7 could regulate cell growth by directly binding to
14-3-3 proteins.23 From the pilot proteomics study, we noticed that
several components of the E-cadherin complex and the 14-3-3 protein
family were associated with the 7-aa peptides (Figure S8A, B). Interest-
ingly, we did not detect peptides from HDAC7 protein. One phosphory-
lated peptide (RATVVESSEK) from the 14-3-3γ protein and two
phosphorylated peptides from the p120 protein (CTNND1) were
detected in the bio-7Ap (MH[pSer[PGAD, which had a synthetically
phosphorylated serine residue) and VEGF-treated bio-7A samples
(Figure S8C). These two proteins might be 7Ap target. In this study, we
focused on 14-3-3γ. The physical binding of bio-7A and bio-7Ap to the
14-3-3γ protein was confirmed by Western blot analysis (Figure 4A). To
test whether 7A was directly involved in 14-3-3γ phosphorylation, the
phosphorylated bio-7A peptide was purified by pull-down assays and
incubated with the commercially available recombinant 14-3-3γ pro-
tein; then, the phosphorylated 7A was detected by ELISA using the
anti-phospho-Ser antibody, and the phosphorylated 14-3-3γ was
detected with Western blot using the anti-phospho-Ser and anti-pho-
spho-Thr antibodies. The phosphorylation signal in bio-7A was
increased by VEGF but was significantly reduced by further incubation
with recombinant 14-3-3γ (Figure 4B, left). No phosphor-Ser bands
were detected, but a phosphor-Thr-positive band, which corresponded
to the 14-3-3γ protein, was detected instead (Figure 4B, right). The
direct incubation of synthetic 7Ap with the recombinant 14-3-3γ pro-
tein in a buffer system increases the threonine phosphorylation of the
14-3-3γ protein (Figure 4C).
As the commercial recombinant 14-3-3γ protein might contain trace
amounts of other proteins that might facilitate the phosphorylation pro-
cess, recombinant 14-3-3γ protein was subjected to SDS-PAGE. The
14-3-3γ band was cut, followed by an in-gel phosphorylation reaction.
As shown in Figure 4D, 7Ap increased the phosphorylation of 14-3-3γ
at a threonine residue. These results suggest that the threonine residue
but not the serine residue within the peptide (RATVVESSEK) is phos-
phorylated and that 7Ap can facilitate the phosphorylation of the threo-
nine residue (Thr145) in 14-3-3γ. Thereafter, we raised a specific
antibody against phosphor-14-3-3γThr145 (p14-3-3γ) with the
KRA(pThr)VVESSEKAYSC peptide. With this antibody, we found that
VEGF could increase the 7A-induced phosphorylation of 14-3-3γ
(Figure 4E). Further immunofluorescence staining revealed that phos-
phorylated 14-3-3γ was located mainly in the nucleus and upregulated
by VEGF treatment, which was significantly enhanced by the presence
of 7A (Figure 4F and Figure S9). Even more interesting, we found that
synthetic phosphor-7A (7Ap) increased 14-3-3γ phosphorylation in the
absence of VEGF treatment (Figure 4F).
3.5 | Adjacent histidine and proline residues were
essential for the phosphorylation transfer
To investigate whether the two adjacent amino acid residues, histidine
and proline, were involved in the phosphorylation transfer, we synthe-
sized a set of mutant 7A peptides (Figure S6B). Peptide pull-down
assays were performed with biotin-labeled 7A or mutant peptides
(Figure S6A) and VEGF-treated/untreated VPC cell lysates. As shown in
Figure 5A, phosphorylated serine could be detected in b-7Ak and b-7Ar
upon VEGF treatment, although it was attenuated compared with b-7A.
There was no phospho-Ser signal in the other three mutants. These
results suggest that an alkaline residue (arginine, histidine, or lysine) on
the left side and a proline on the right side are essential for the receipt
of the phosphate group to the serine residue in the 7A peptide. To fur-
ther assess whether these substitutions affected the 7Ap to facilitate
the target protein phosphorylation, recombinant 14-3-3γ was incubated
with the synthetic phosphorylated mutant 7A peptides, and 14-3-3γ
phosphorylation was determined by Western blot analysis. As shown in
Figure 5B, all the substitutions lost the ability to facilitate 14-3-3γ
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F IGURE 4 Phosphorylated 7A transferred the phosphate group to 14-3-3γT145. A, Phosphorylated 7A physically interacted with 14-3-3γ. The
bio-peptide/protein complex was trapped by streptavidin beads and subjected toWestern blot analysis with anti-14-3-3γ antibody. B, The peptide
7A mediated 14-3-3γ phosphorylation at threonine residues. Biotin-labeled peptides/streptavidin beads were incubated with cell lysate from vascular
endothelial growth factor (VEGF)-treated Sca1+-VPCs. After being washed with sodium dodecyl sulfate (SDS) solution, the beads were incubated
with 10 ng of 14-3-3γ and eluted with SDS solution. The beads were subjected to enzyme-linked immunosorbent assay with anti-phospho-Ser (pSer)
antibody (Left), whereas the eluate was subjected toWestern blotting (right). C, The synthetic 7Ap phosphorylated 14-3-3γ. The 14-3-3γ protein
(10 ng) was incubated with peptides (1 ng) in a cell-free buffer system followed byWestern blotting. Fifty micrograms VEGF-treated Sca1+-VPCs
lysate was included as a positive control (ctl). D, The 7Ap peptide phosphorylated 14-3-3γ in gel. The 14-3-3γ bands were cut from the sodium
dodecyl sulfate-polyacrylamide gel electrophoresis gel, renatured and incubated with peptides. The gel sections were rearranged and transferred to a
polyvinylidene difluoride membrane followed byWestern blot analysis. E, The 7A peptide enhanced VEGF-mediated 14-3-3γ phosphorylation.
Sca1+-VPCs(1 × 106) were pretreated with 1 ng/mL 7S or 7A for 1 hour and then treated with 5 ng/mL VEGF in the presence of the peptides for the
time indicated followed byWestern blot analysis. F, The 7Ap peptide induced 14-3-3γ phosphorylation and nuclear translocation. The Sca1+-VPCs
(1 × 106) were pretreated with 1 ng/mL 7S or 7Sp (phosphorylated 7S) or 7A or 7Ap for 1 hour, treated with 5 ng/mL VEGF in the presence of the
peptides for 30 minutes, and subject to immunofluorescence staining with anti-phospho-14-3-3γThr145 (p14-3-3γ) and anti-14-3-3γ antibodies.
Quantification was presented in Figure S4. Phosphate-buffered saline and bovine serum albumin were included as control for peptides and VEGF,
respectively. Scale bar: 25 μm. The data presented are representative images or mean values of three independent experiments. For statistical
analysis, the two-way analysis of variance (ANOVA) followed by Tukey's multiple comparisons test was used in (A) and (B); the one-way ANOVA
followed by Holm-Sidak's multiple comparisons test was used in (C) and (D); Student's t test was used in (E). *P < .05. VPC, vascular progenitor cell
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phosphorylation, suggesting that histidine and proline are essential for
facilitating phosphorylation.
Histidine is one of the four amino acids that can be phosphory-
lated at the N1 and/or N3 site in its imidazole ring in both bacterium
and eucaryon.24,25 As described above, the histidine residue was not
essential for phosphorylation at the serine residue in the 7A peptide
but was critical for the phosphorylation of 14-3-3γ; thus, we won-
dered whether there was an intramolecular phosphorylation transfer
between the histidine and serine residues within the 7Ap peptide.
Indeed, phosphorylated histidine at the N1 but not N3 position could
be detected in synthetic 7Ap but not in 7SP or 7Avp, as revealed by
micro-titer plate-coating/ELISA assays (Figure 5C). As expected, the
phospho-Ser signal was significantly lower in 7Ap compared with
other mutants or 7Sp (Figure 5D). As the N-terminal labeling of 7A
with biotin might block the access of the antibody to the phosphory-
lated histidine, we synthesized a C-terminal biotin-labeled 7Ap-b
instead. Indeed, b-7Ap showed a negligible phosphor-His signal, but
7Ap-b had a histidine phosphorylation signal similar to that of 7Ap
(Figure 5C). The intramolecular phosphorylation transfer may facilitate
the phosphate group transfer from 7Ap to the 14-3-3γ protein.
3.6 | MEKK1, 7A, and 14-3-3γ formed a signaling
pathway that contributed to Sca1+-VPC migration
Having verified that 7A receives a phosphate group from the activated
MEKK1 and in turn facilitates 14-3-3γ phosphorylation, we assessed
whether 7A acted as a bridge between MEKK1 and 14-3-3γ. As shown
in Figure 6A, the knockdown of Mekk1 by siRNA abolished VEGF-
induced 14-3-3γThr145 phosphorylation and MKK4Ser257/Thr261
phosphorylation,26 indicating that MEKK1 is an upstream kinase for
14-3-3γ phosphorylation. In Mekk1 knockdown Sca1+-VPCs, the addi-
tion of 7Ap alone induced 14-3-3γThr145 phosphorylation, although
VEGF treatment reduced 7Ap-mediated 14-3-3γThr145 phos-
phorylation (Figure 6B). The Sca1+-VPCs were isolated from WT,
Hd7-7sFLAG+/− (HZ), and Hd7-7sFLAG+/+ (KO) mice, treated with VEGF
and subjected to Western blot analysis for 14-3-3γ phosphorylation. As
F IGURE 5 Histidine and proline were essential for the phosphate transfer. A, The alkaline and proline residues flanking the serine residue were
essential for phosphorylation upon vascular endothelial growth factor (VEGF) treatment. Biotin-labeled peptides were incubated with cell lysates
from VEGF-treated/untreated vascular progenitor cells (VPCs) and subjected to streptavidin-agarose bead pulldown assays and enzyme-linked
immunosorbent assays (ELISAs) with an anti-phospho-Ser antibody. B, Both histidine and proline were critical for phosphorylating 14-3-3γ. 14-3-3γ
(10 ng) was incubated with phosphorylated peptides (1 ng) in a cell-free buffer system and subjected to Western blots with anti-phospho-
14-3-3γThr145 (p14-3-3γ) and anti-14-3-3γ antibodies. C, D, The phosphate group could be transferred from serine to histidine intramolecularly.
Phosphorylated peptides (10 μg) were coated onto microtiter plates and subjected to ELISAs with anti-phospho-His (1-pHis and 3-pHis) (C) and
phospho-Ser (D) antibodies. In addition, 50 μg of VEGF-treated VPC cell lysate was included as a positive control for phosphor-histidine. The data
presented are representative images or the mean of three values of independent experiments. For statistical analysis, Student's t test was used in
(A) and the one-way analysis of variance followed by Holm-Sidak's multiple comparisons test was used in (B)-(D). *P < .05; **P < .01
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shown in Figure 6C, VEGF induced 14-3-3γ phosphorylation in WT
Sca1+-VPCs, but the effect was significantly attenuated in HZ Sca1+-
VPCs and abolished in KO Sca1+-VPCs. There was no difference on the
basal level of HDAC7 protein between Sca1+-VPCs from WT and KO
mice. There seemed higher HDAC7 proteins in Sca1+-VPCs from HZ
mice. VEGF treatment decreased the HDAC7 protein level in Sca1+-
VPCs fromWT and HZ mice but not in those from KOmice (Figure 6C).
Further experiments detected fewer phosphor-14-3-3γT145 positive
cells in the vessel wall of KO mice compared with WT mice, which were
subjected to femoral artery injury and sacrificed at day 3 postsurgery
(Figure 6D). Local delivery of synthetic 7A peptide via Pluronic F-127
gel significantly increased phosphor-14-3-3γT145 positive cells in KO
mice, even more than that in WT mice (Figure 6D). These results con-
firm that MEKK1, 7A, and 14-3-3γ form a signaling pathway down-
stream of VEGF treatment.
It is well established that local resident stem/progenitor cells con-
tribute to vascular injury repair or disease development, which involves
the mobilization of stem/progenitor cells from the stem cell niche and
differentiation toward vascular lineages.14,27 To test the cellular func-
tion of the 7A-peptide, transwell migration assays were implicated to
explore the effect of 7A on Sca1+-VPC mobilization. As shown in
Figure 7A, 7A increased Sca1+-VPC migration and dramatically
F IGURE 6 The MEKK1, 7A, and 14-3-3γ formed a novel signaling pathway downstream vascular endothelial growth factor (VEGF). A,
Knockdown ofMekk1 abolished VEGF-induced 14-3-3γ phosphorylation in differentiated Sca1+-VPCs. The Sca1+-VPCs were transfected with
Mekk1 siRNA (Mekk1si) and cultured for 3 days, then treated with 5 ng/mL of VEGF in serum-free medium for 30 minutes, followed by Western
blotting with anti-phospho-MEKK1Ser393 (pMEKK1), anti-MEKK1, anti-phospho-14-3-3γThr145 (p14-3-3γ), and anti-14-3-3γ antibodies. Control
siRNA (ctlsi) and GAPDH were included as siRNA and loading controls. pM/M/G: pMEKK1/MEKK1/ GAPDH; p14/14/G: p14-3-3γ/14-3-3γ/
GAPDH. B, The 7Ap-peptide induced 14-3-3γ phosphorylation independent of MEKK1. TheMekk1 knockdown Sca1+-VPCs were pretreated with
1 ng/mL peptides for 1 hour and then treated with 5 ng/mL VEGF for 30 minutes, followed by Western blotting with anti-phospho-14-3-3γThr145
(p14-3-3γ) and anti-14-3-3γ antibodies. Phosphate-buffered saline and 1% bovine serum albumin were included as vehicle controls for peptide and
VEGF, respectively. GAPDH was included as a loading control. C, 7A deficiency abolished VEGF-induced 14-3-3γ phosphorylation. The Sca1+-VPCs
were isolated from wild-type (WT), heterozygous (HZ), and homozygous (KO) mice arteries and treated with 5 ng/mL VEGF for 30 minutes, followed
by Western blot analysis of 14-3-3γ phosphorylation. 14-3-3γ and GAPDH were included as loading controls. Note that HDAC7 expression was not
affected by the transgenic handling. D, Local delivery of synthetic 7A-peptide rescued 14-3-3γ phosphorylation in KO mice. Double
immunofluorescence staining with anti-Sca1 (red) and anti-p14-3-3γT145 (green) antibodies was performed on the sections isolated from the
femoral artery injured WT and KO mice 3 days postsurgery. In KO + 7A group, 200 μL of Pluronic F-127 gel containing 10 ng/mL 7A was applied to
the injury sites. Five mice were used for each group. The data presented are representative images or mean values of three independent
experiments. For statistical analysis, the two-way analysis of variance followed by Tukey's multiple comparisons test was used *P < .05. VPC,
vascular progenitor cell
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enhanced VEGF-induced Sca1+-VPC migration, whereas 7Ap alone was
as effective as VEGF treatment. Interestingly, VEGF treatment attenu-
ated 7Ap-mediated VPC migration similar to 7Ap-mediated 14-3-3γ
phosphorylation. The knockdown of Mekk1 ablated VEGF- and 7A- but
not 7Ap-induced Sca1+-VPC migration (Figure 7B). However, the
knockdown of 14-3-3γ abolished the Sca1+-VPC migration induced by
all factors (Figure 7B). Further experiments with Sca1+-VPCs isolated
from Hd7-7sFLAG transgenic mice revealed that 7A deficiency
abolished VEGF-induced migration (Figure 7C). Therefore, these results
demonstrate that the MEKK1/7A/14-3-3γ pathway is responsible for
VEGF-induced cell migration in Sca1+-VPCs.
4 | DISCUSSION
Recent studies indicate that one mRNA molecule can actually encode
several peptides through different strategies including multiple ORFs
or non-AUG codon-initiated translation, ribosomal frame shifting, stop
codon read through, and termination-dependent reinitiation.28-31
Hundreds of putative coding sORFs have been identified by comput-
ing, proteomics, and ribosomal profiling, some of which have been
confirmed.32,33 Recently, Anderson et al reported that a functional
5KDa small peptide, myoregulin, could be translated from a putative
long noncoding RNA.34 In this study, we demonstrate that a sORF
within the 50-UTR of mouse Hdac7 transcript variant 2 can be trans-
lated to produce a 7-aa peptide.
Our previous study has demonstrated that the Hdac7 transcript var-
iant 2 could undergo further splicing to remove 57 nucleotides intron,
joining the sORF with main ORF.17 In this study, the FISH experiments
demonstrated the existence of the intron-containing mRNA in the cyto-
sol. Most importantly, the puromycin-induced signal enhancement
strongly suggests that ribosome binds to the sORF. The binding of the
ribosomes may lead to the translation of the sORF alone as there are
F IGURE 7 The MEKK1-7A-14-3-3γ pathway contributed to vascular progenitor cell (VPC) migration. A, 7A enhanced vascular endothelial
growth factor (VEGF)-induced VPC (5 × 104) migration as revealed by transwell migration assays. Scale bar: 100 μm. B, Mekk1 and 14-3-3γ
knockdown abolished VEGF-mediated VPC migration. Transwell migration assays were performed using VPC (5 × 104) transfected with control
siRNA (ctlsi), Mekk1 siRNA (Mekk1si), and 14-3-3γ siRNA (14-3-3γsi) and treated with 1 ng/mL peptides and 5 ng/mL VEGF. C, 7A deficiency
abolished VEGF-induced migration. Transwell migration assays were performed on VPCs isolated from wild-type (WT), heterozygous (HZ), and
homozygous (KO) mouse siblings. The left panels show crystal violet staining images, whereas the right panels show the mean values of the
migrated cells for each image. Data are presented as mean ± SD, n = 15 cell cultures from six mice per experimental group. The data presented
are representative images or as mean ± SD, n = 15 cell cultures per group of three independent experiments. For statistical analysis, two-way
analysis of variance followed by Tukey's multiple comparisons test was used in (A) and (B) and the Student's t test was used in
(C). *P < .05; **P < .01
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three cascade in-frame stop codons. The direct evidence for the transla-
tion of the sORF is derived from the observation on the non-
overlapping of 7A and HDAC7 double immunofluorescence staining. If
the 7A sequence exists in the N-terminal of HDAC7 protein, the double
staining should give an overlapped pattern due to the proximity that
forms the basis of investigation on the protein-protein interaction.
Although we did observe overlapped staining of 7A and HDAC7
in vitro and in vivo, the non-overlapped staining obviously existed, indi-
cating that the sORF and mORF can be translated separately. The sepa-
rate translation of these ORFs may provide a novel mechanism to
regulate HDAC7 protein level, that is, the translation shift, in addition
to the transcriptional suppression or posttranslational degradation by
protein kinase D-mediated phosphorylation.35,36 The translation of the
sORF and main ORF may be regulated separately. The binding of ribo-
some to the sORF may be mediated by the classic G-N7-cap struc-
ture.37 The three in-frame sequential stop codons may guarantee the
translation of the 7-aa peptide stop effectively, avoiding the stop-codon
read through or reinitiation.31,38,39 There may exist some noncoding
RNAs or RNA-binding proteins that bind to the sORF to block the
access of ribosome under unstimulated conditions. Under stimulated
conditions, these blocking factors are removed, and therefore ribo-
somes can access to sORF and initiate its translation. The binding and
translation of the main ORF may be mediated through a similar mecha-
nism as internal ribosomal entry site.40 We cannot exclude the “shift
translation” mechanism, which will shift the translation of the 7A-
peptide to the full length HDAC7 protein under some specific circum-
stances. The overlapped 7A/HDAC7 signal reflects the further splicing
of Hdac7 mRNA to join the sORF and main ORF to produce a full
length HDAC7 protein, the translation of which is still initiated from the
ATG codon within the sORF. VEGF treatment increased both non-
overlapped and overlapped signals in VPCs, suggesting that VEGF can
increase Hdac7 mRNA further splicing and translation initiation from
the ATG codon within the sORF. Further detailed investigation will be
required to explore the exact mechanisms involved in the separate
translation of the sORF and main ORF. Interestingly, similar sORFs also
exist in the predicted human (MHSPGAGWK in XM_011538479) and
Heterocephalus glaber (MHSPGADGTG, XM_004863129) HDAC7
mRNAs. There are also other sORFs in the 50-UTR of all transcript vari-
ants. Detailed investigation will be required to explore whether such
sORFs are also translatable and what are the underlying mechanisms
for the translational regulation of the sORF.
HDAC7 negatively regulates cell migration and proliferation via for-
ming a complex with β-catenin/E-cad.41-43 Mitogenic factors down-
regulate HDAC7 via transcriptional suppression or posttranslational
degradation by protein kinase D-mediated phosphorylation35,36; this
process leads to the disruption of HDAC7/β-catenin/E-cad. During this
process, the kinase undergoes a phosphorylation-to-dephosphorylation
shift. Phosphorylation usually occurs at serine, threonine, tyrosine, and
histidine residues in eukaryotic proteins.44-47 Normally, a kinase has
multiple phosphorylation sites, and each site may correspond to a set of
substrates. Therefore, a kinase can participate in different cellular pro-
cesses via receiving phosphate groups at different sites and transferring
the phosphate groups to different substrates.
MEKK1 is a serine/threonine kinase that participates in multiple
cellular processes, particularly in cell survival and apoptosis regula-
tion.48 There are currently two commercially available phosphor-
antibodies for detecting the phosphorylation of MEKK1 at threonine
residues 1383 and 1400. In the present study, we identified a new
phosphorylation site, serine 393, which was activated by VEGF stimu-
lation. MEKK1 can phosphorylate kinases, such as MKK4,26 Raf/
ErK,49 and JNK50, and non-kinase proteins, such as AXIN151 and
14-3-3 proteins.48 The 7Aa-induced MEKK1S393 phosphorylation
retention, in which the phosphorylatable serine residue in the 7A pep-
tide is substituted with an unphosphorylatable alanine, suggests that
the 7A peptide or 7A-containing peptides or proteins may be the sub-
strates of MEKK1S393 phosphorylation. During the phosphate group
transfer, 7A or 7Aa binds to the MEKK1S393 motif. The adjacent
alkaline amino acid may facilitate the access of the serine residue in
7A to the phosphorylated S393 in MEKK1 through an electronic inter-
action between an NH+ and PO4
−. The bond between the hydroxyl
group (OH) and PO4
− in S393 is broken, whereas the bond between
OH and PO4
− in the serine residue in 7A is formed; during this pro-
cess, the pyrrolidine ring in proline may facilitate the OH/PO4
− bond
disruption and re-formation, thus transferring the phosphate group
from MEKK1S393 to the serine residue in 7A. Phosphorylated 7A
undergoes a conformational change, losing its affinity to MEKK1, and
thus dissociates from MEKK1. The alanine in 7Aa cannot receive the
phosphate group, leaving it stuck to MEKK1, and the PO4
− remains at
the MEKK1S393 site, which is reflected by the increased binding
between 7Aa and phosphorylated MEKK1 and the high level of
MEKK1S393 phosphorylation. In addition to MEKK1, other kinases
may also contribute to 7A phosphorylation, asMekk1 knockdown only
attenuated but did not totally block 7A phosphorylation. Proteomic
analysis also detected other kinases that were associated with the 7A
peptide. Detailed investigation will be required.
As described above, MEKK1 can associate with 14-3-3 proteins.48
Our present study also showed that 14-3-3γ phosphorylation at thre-
onine 145 was MEKK1-dependent because Mekk1 knockdown
abolished VEGF-induced 14-3-3γ phosphorylation at this site. Even
more interesting, we found that synthetic phosphor-7A (7Ap) could
facilitate 14-3-3γT145 phosphorylation in a cell-free SDS-PAGE run-
ning gel system. Thus, MEKK1 can phosphorylate 14-3-3γ in either a
physical interaction-dependent or interaction-independent way. In
the independent mode, 7Ap acts as the messenger. The 7Ap depen-
dent 14-3-3γT145 phosphorylation is also sequence-dependent, and
the adjacent histidine and proline are essential. As the arginine or
lysine replacement of histidine does not stop 7A phosphorylation, the
serine acts as the receptor residue for the phosphate group. There
must be an intramolecular exchange of the phosphate group from the
serine residue to the histidine residue because phosphorylated histi-
dine could be detected in synthetic serine-phosphorylated 7Ap. This
intramolecular exchange is essential for the phosphate group transfer
from 7Ap to target proteins. Upon binding to the substrate, the histi-
dine residue in 7A may access the hydroxyl group in the threonine
residue via NH+/OH interaction; during this process, the pyrrolidine
ring may facilitate the intramolecular phosphate shift from the serine
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residue to the N1 site of the imidazole ring of histidine, and the phos-
phate is then transferred to the OH group within the threonine resi-
due of the target protein. The pyrrolidine ring plays a critical role in
the receipt and transfer of the phosphate group, as substitution with
valine (which has the same number of carbons) abolishes this process.
This might be the first study showing that a small peptide can transfer
phosphorylation. It may be reminiscent of the early stage of evolution,
when the small peptides and DNA/RNA oligos dominated the earth
and evolved into large molecules. Although VEGF activated the
MEKK1-7A-14-3-3γ signal pathway, we also noticed that the exoge-
nous synthetic 7Ap-mediated 14-3-3γ phosphorylation and VPC
migration was attenuated by VEGF. This phenomenon provided sup-
port on the notion that 14-3-3γ phosphorylation contributes to VPC
migration on one hand. On the other hand, VEGF may also activate
some negative feedback mechanisms to avoid an overreactive
MEKK1-7A-14-3-3γ signal pathway. For example, VEGF may increase
the interaction of phosphorylated 7A or 14-3-3γ protein with phos-
phatases like cdc25A.52 In Mekk1si knockdown VPCs, VEGF had no
effect on 7Ap-mediated migration, different from the control siRNA-
transfected cells. These results suggest that MEKK1 may be also
involved in cell migration in 14-3-3γ-independent pathway. Detailed
investigation will be required.
Importantly, the endogenous 7A peptide was undetectable in the
uninjured femoral arterial wall but was significantly increased in Sca1+-
VPCs in response to injury, suggesting that 7A may be translated in only
activated progenitor cells. It has been reported that vascular resident
stem/progenitor cells contribute to vascular remodeling.53-56 Sca1+-
VPCs can differentiate into both ECs and smooth muscle cells.57,58 When
differentiating toward the EC lineage, Sca1+-VPCs may contribute to vas-
cular injury repair and angiogenesis. Indeed, in this study, we noted that
the 7A-deficient mice had fewer Sca1+-VPCs in the injured vessel wall
and ischemic tissues, which led to slower re-endothelialization in the
injured vessels and angiogenesis deterioration in the ischemic tissues.
However, local delivery of the exogenous 7A peptide significantly
increased the number of Sca1+-VPCs. Therefore, re-endothelialization
and angiogenesis were significantly improved. Thus, this study provided
strong evidence for the contribution of Sca1+-VPCs to vascular injury
repair and angiogenesis in ischemic tissues. Using different cell surface
markers, different groups have identified different types of vessel wall-
resident stem/progenitor cells that contribute to neo-angiogenesis.59-61
In this study, we have demonstrated that 7A was essential for neo-
angiogenesis in response to vascular injury. We also detected 7A expres-
sion in Sca1− cells. It will be interested to investigate whether 7A is also
expressed in the Procr+, PW1+, or CD157+ progenitor cells and involved
in the progenitor cells-mediated neo-angiogenesis. It will be also worthy
to investigate the differentiation of these different types of progenitor
cells in vivo via lineage tracing. Denudation of the endothelium is the ini-
tial step of atherosclerosis.62 Although endothelium denudation was
maintained much longer in the injured vessels of the KO mice than in
those of the WT mice, we did not observe obvious neointima formation
within 3 weeks postsurgery. This finding may be due to the short time
period or the decreased number of Sca1+-VPCs in the vessel wall, which
may support the notion that local resident progenitor cells contribute to
vascular disease development.55 Local delivery of the exogenous 7A pep-
tide slightly decreased the media thickness, which may suggest that 7A
can suppress smooth muscle cell proliferation. However, a detailed inves-
tigation will be required.
Different from the HDAC7 protein, which is indispensable for
embryonic development,9 the 7A peptide is dispensable, although 7A-
positive cells can be detected at the embryonic stages. 7A-deficient
mice can survive with apparent phenotype of body weight gain under
normal diet. As the 7 seconds-FLAG replacement may affect Hdac7
mRNA transcript variant 2 undergoing further splicing, we cannot
exclude the possibility that some of the phenotypes observed may be
due to the lack of full-length HDAC7 protein. Some of the phenotypes
may be due to lack of 7A, some due to lack of full-length HDAC7, and
some due to the combined effect from the lack of both 7A and full-
length HDAC7 protein. The transgenic mice will also serve a good
model to investigate the function of full-length HDAC7 protein, espe-
cially in heart functions, as we have detected the full length of
HDAC7 in coronary arteries in wild-type mice. However, the rescue
effect by the exogenous 7A-peptide still provides strong evidence for
the endogenous 7A-mediated functions. Considering that 7A was
detected in only the injured vessel walls and that 7A deficiency con-
siderably slowed injured vessel re-endothelialization and reduced
angiogenesis in ischemic tissues, we can assume that the alternative
translation of the 7A peptide is a pathological response. Therefore,
the exogenous 7A peptide and its more active form, 7Ap, may possess
therapeutic potential for vascular injury or angiogenesis-related dis-
ease intervention.
In summary, VEGF or pathological stimulus induces translation of
the sORF from Hdac7mRNA in Sca1+-VPCs. On the one hand, this pro-
cess produces a 7-aa peptide (7A). On the other hand, the exogenous
stimulus activates MEKK1 via phosphorylation at the Ser393 residue.
Activated MEKK1 transfers the phosphate group from Ser393 to the
serine residue of the 7-aa peptide. The intramolecular serine-to-
histidine phosphate transfer may affect 7Ap confirmation and therefore
affect its affinity to 14-3-3γ protein, facilitating its phosphorylation,
leading to the cadherin-plakoglobin-catenin-14-3-3γ complex disruption
and 14-3-3γ nuclear translocation. Other signaling pathways may also
contribute to and/or be activated by 7A phosphorylation. The overall
effect leads to Sca1+-VPC migration and differentiation toward the EC
lineage; these effects contribute to vascular injury repair and angiogene-
sis in ischemic tissue (Figure S10). The significance of this study is that
small peptides, such as 7A, can play an important role in multiple physi-
ological and pathological processes via functioning as novel signaling
messengers to expand the substrate spectrum of kinases.
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